Structure-guided drug repurposing identifies aristospan as a potential inhibitor of β-lactamase: insights from virtual screening and molecular dynamics simulations
The rise of β-Lactamase mediated antibiotic resistance is a major concern for public health; hence, there is an urgent need to find new treatment approaches. Structure-guided drug repurposing offers a promising approach to swiftly deliver essential therapeutics in the fight against escalating antibi...
Saved in:
| Main Authors: | Moyad Shahwan, Mohd Shahnawaz Khan, Azna Zuberi, Nojood Altwaijry, Anas Shamsi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1459822/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Potential Inhibitors of Histone Deacetylase 6 Through Virtual Screening and Molecular Dynamics Simulation Approach: Implications in Neurodegenerative Diseases
by: Anas Shamsi, et al.
Published: (2024-11-01) -
Identification of potential inhibitors of Ubiquitin carboxyl-terminal hydrolase 21 from repurposed drugs: Implications in anticancer therapeutics
by: Anas Shamsi, et al.
Published: (2025-06-01) -
Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations
by: Mohd Shahnawaz Khan, et al.
Published: (2025-08-01) -
Structure-guided virtual screening reveals phytoconstituents as potent cathepsin B inhibitors: Implications for cancer, traumatic brain injury, and Alzheimer’s disease
by: Nageeb Hassan, et al.
Published: (2025-04-01) -
Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions
by: Mohammed Alrouji, et al.
Published: (2024-11-01)